Compare GEVO & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEVO | NNOX |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 253.8M |
| IPO Year | 2011 | 2020 |
| Metric | GEVO | NNOX |
|---|---|---|
| Price | $2.23 | $3.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.13 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 3.2M | 2.6M |
| Earning Date | 11-10-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,932,000.00 | $12,302,000.00 |
| Revenue This Year | $927.85 | $20.19 |
| Revenue Next Year | $12.01 | $137.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 675.75 | 15.19 |
| 52 Week Low | $0.92 | $2.78 |
| 52 Week High | $2.98 | $11.00 |
| Indicator | GEVO | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 49.38 |
| Support Level | $1.83 | $3.62 |
| Resistance Level | $2.42 | $3.88 |
| Average True Range (ATR) | 0.12 | 0.37 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 70.34 | 45.07 |
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.